 "I am doing fine after taking a two-week course of hydroxychloroquine: Trump")
President Donald Trump says he's doing fine after taking a two-week course of an unproven malaria drug for Covid-19.
Trump was addressing his disclosure last week that he was taking hydroxychloroquine and a zinc supplement. He said the regimen was meant to help prevent infection after two White House staffers tested positive for the coronavirus.
Trump has spent weeks pushing the drug as a potential treatment or prophylaxis for Covid-19 against the cautionary advice of many of his administration's top medical professionals.
Speaking in an interview aired on the Sunday news program Full Measure with Sharyl Attkisson, Trump said that "I just finished the course of drug treatments and to the best of my knowledge, here I am. If it's something that helps, that's all I want."
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%